Chromoblastomycosis

Clin Dermatol. 2012 Jul-Aug;30(4):403-8. doi: 10.1016/j.clindermatol.2011.09.011.

Abstract

Chromoblastomycosis is a chronic, subcutaneous mycosis, characterized by verrucous nodular lesions, usually involving the legs and mainly caused by Fonsecaea, Phialophora, and Cladophialophora spp. The characteristic finding on direct examination or biopsy specimen is the presence of fumagoid cells or Medlar bodies. Chromoblastomycosis can be refractory to medical treatment. Therapeutic options include oral itraconazole, terbinafine, or 5-fluocytosine, alone or combined with surgery or cryosurgery.

MeSH terms

  • Adolescent
  • Adult
  • Antifungal Agents / therapeutic use*
  • Ascomycota / isolation & purification*
  • Chromoblastomycosis / drug therapy*
  • Chromoblastomycosis / pathology
  • Chromoblastomycosis / surgery
  • Cryosurgery / methods*
  • Drug Therapy, Combination
  • Female
  • Fluconazole / therapeutic use
  • Humans
  • Itraconazole / therapeutic use
  • Male
  • Middle Aged
  • Mitosporic Fungi / isolation & purification*
  • Naphthalenes / therapeutic use
  • Terbinafine
  • Young Adult

Substances

  • Antifungal Agents
  • Naphthalenes
  • Itraconazole
  • Fluconazole
  • Terbinafine